FDA Clears AI Technology That Evaluates Echocardiograms | MedStar Health

FDA Clears AI Technology That Evaluates Echocardiograms

Share this

Neil J. Weissman, MD, chief scientific officer for MedStar Health, served as an unbiased adjudicator and reviewer of the new technology which is expected to improve cardiovascular disease management and patient outcomes through earlier detection and monitoring. EchoMD AutoEF software was released by Bay Labs and has received 510(k) clearance from the U.S. Food and Drug Administration. Read More.